The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy

详细信息    查看全文

• 作者：Beth A. Erickson¹ ; ^{berickson@mcw.edu} ; Nathan H.J. Bittner² ; Manjeet Chadha³ ; Firas Mourtada⁴ ; D. Jeffrey Demanes⁵
• 关键词：High-dose-rate brachytherapy ; HDR brachytherapy ; Radionuclides ; Radiation therapy ; Radioactive sources ; Oncologic practice ; Radiation oncologist
• 刊名：Brachytherapy
• 出版年：2017
• 出版时间：January-February 2017
• 年：2017
• 卷：16
• 期：1
• 页码：75-84
• 全文大小：291 K
• 卷排序：16

文摘

Brachytherapy is a radiation therapy method in which radionuclide sources are used to deliver a radiation dose at a distance of up to a few centimeters by surface, intracavitary, intraluminal, or interstitial application. This practice parameter refers only to the use of radionuclides for brachytherapy. Brachytherapy alone or combined with external beam therapy plays an important role in the management and treatment of patients with cancer. High-dose-rate (HDR) brachytherapy uses radionuclides such as iridium-192 at dose rates of 20 cGy per minute (12 Gy per hour) or more to a designated target point or volume. High-dose-rate (HDR) brachytherapy is indicated for treating malignant or benign tumors where the treatment volume or targeted points are defined and accessible.